Chemotactic peptide analogues. Centrally constrained chemotactic N-formyltripeptides: synthesis, conformation, and activity of two new analogues. 1996

G Pagani Zecchini, and M Paglialunga Paradisi, and I Torrini, and G Lucente, and G Mastropietro, and M Paci, and S Spisani
Dipartimento di Studi Farmaceutici, Università La Sapienza, Roma, Italy.

The role exercised by the central residue of the chemotactic N-formyltripeptide HCO-Met-Leu-Phe-OMe (fMLP-OMe) in controlling both the backbone conformation and the biochemical activity is the subject of recent interest. Here, two new centrally constrained fMLP-OMe analogues, namely HCO-Met-azaPro-Phe-OMe (4) and HCO-Met-(gamma-lactam)-Phe-OMe (6) have been synthesized and their CDCI3 solution conformation and activity have been studied. The azapeptide 4 adopts beta-folded conformation with the azaPro residue at the i+2 position and an intramolecular H-bond involving the formylic oxygen and the Phe NH. The gamma-lactam tripeptide 6 prefers a semi-extended backbone conformation. When tested on human neutrophils both the new models were found practically devoid of biological activity. The role exerted by the NH groups as well as by the conformational preferences is discussed.

UI MeSH Term Description Entries
D009240 N-Formylmethionine Leucyl-Phenylalanine A formylated tripeptide originally isolated from bacterial filtrates that is positively chemotactic to polymorphonuclear leucocytes, and causes them to release lysosomal enzymes and become metabolically activated. F-Met-Leu-Phe,N-Formyl-Methionyl-Leucyl-Phenylalanine,Formylmet-Leu-Phe,Formylmethionyl Peptide,Formylmethionyl-Leucyl-Phenylalanine,Formylmethionylleucylphenylalanine,N-Formylated Peptide,N-formylmethionyl-leucyl-phenylalanine,fMet-Leu-Phe,F Met Leu Phe,Formylmet Leu Phe,Formylmethionyl Leucyl Phenylalanine,Leucyl-Phenylalanine, N-Formylmethionine,N Formyl Methionyl Leucyl Phenylalanine,N Formylated Peptide,N Formylmethionine Leucyl Phenylalanine,N formylmethionyl leucyl phenylalanine,Peptide, Formylmethionyl,Peptide, N-Formylated,fMet Leu Phe
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002633 Chemotaxis The movement of cells or organisms toward or away from a substance in response to its concentration gradient. Haptotaxis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

G Pagani Zecchini, and M Paglialunga Paradisi, and I Torrini, and G Lucente, and G Mastropietro, and M Paci, and S Spisani
February 1990, International journal of peptide and protein research,
G Pagani Zecchini, and M Paglialunga Paradisi, and I Torrini, and G Lucente, and G Mastropietro, and M Paci, and S Spisani
September 2007, Amino acids,
G Pagani Zecchini, and M Paglialunga Paradisi, and I Torrini, and G Lucente, and G Mastropietro, and M Paci, and S Spisani
January 1984, FEBS letters,
G Pagani Zecchini, and M Paglialunga Paradisi, and I Torrini, and G Lucente, and G Mastropietro, and M Paci, and S Spisani
August 1987, International journal of peptide and protein research,
G Pagani Zecchini, and M Paglialunga Paradisi, and I Torrini, and G Lucente, and G Mastropietro, and M Paci, and S Spisani
November 1987, Il Farmaco; edizione scientifica,
G Pagani Zecchini, and M Paglialunga Paradisi, and I Torrini, and G Lucente, and G Mastropietro, and M Paci, and S Spisani
January 1991, Peptide research,
G Pagani Zecchini, and M Paglialunga Paradisi, and I Torrini, and G Lucente, and G Mastropietro, and M Paci, and S Spisani
October 1991, The Journal of biological chemistry,
G Pagani Zecchini, and M Paglialunga Paradisi, and I Torrini, and G Lucente, and G Mastropietro, and M Paci, and S Spisani
September 1987, Journal of medicinal chemistry,
G Pagani Zecchini, and M Paglialunga Paradisi, and I Torrini, and G Lucente, and G Mastropietro, and M Paci, and S Spisani
May 2007, Organic letters,
G Pagani Zecchini, and M Paglialunga Paradisi, and I Torrini, and G Lucente, and G Mastropietro, and M Paci, and S Spisani
December 2003, Biopolymers,
Copied contents to your clipboard!